"Pfizer announced a new breakthrough Friday that vastly extends the lifespan of near-death patents."
You have to read this carefully. Because "nothing causes Pfizer officials more distress than seeing a once robust patent expire at a young age, a “terrible tragedy” that allows dozens of generic manufacturers to copy it and offer pharmaceuticals to customers far more cheaply."
No comments:
Post a Comment